Friedrich Kapp

1.4k total citations
24 papers, 357 citations indexed

About

Friedrich Kapp is a scholar working on Surgery, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Friedrich Kapp has authored 24 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 5 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Friedrich Kapp's work include Vascular Malformations and Hemangiomas (11 papers), Vascular Tumors and Angiosarcomas (5 papers) and Tumors and Oncological Cases (5 papers). Friedrich Kapp is often cited by papers focused on Vascular Malformations and Hemangiomas (11 papers), Vascular Tumors and Angiosarcomas (5 papers) and Tumors and Oncological Cases (5 papers). Friedrich Kapp collaborates with scholars based in Germany, Switzerland and Spain. Friedrich Kapp's co-authors include M. Winkelmann, Volker Auwärter, Maren Hermanns‐Clausen, Hans H. Maurer, Bernard Haendler, Thomas Kiefer, Anette Sommer, Gottfried Dölken, Charlotte M. Niemeyer and Jochen Rößler and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Friedrich Kapp

23 papers receiving 345 citations

Peers

Friedrich Kapp
Lili Chi China
Friedrich Kapp
Citations per year, relative to Friedrich Kapp Friedrich Kapp (= 1×) peers Lili Chi

Countries citing papers authored by Friedrich Kapp

Since Specialization
Citations

This map shows the geographic impact of Friedrich Kapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrich Kapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrich Kapp more than expected).

Fields of papers citing papers by Friedrich Kapp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedrich Kapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrich Kapp. The network helps show where Friedrich Kapp may publish in the future.

Co-authorship network of co-authors of Friedrich Kapp

This figure shows the co-authorship network connecting the top 25 collaborators of Friedrich Kapp. A scholar is included among the top collaborators of Friedrich Kapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedrich Kapp. Friedrich Kapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Andrade, Jorge, Ana Rita Grosso, Rui Benedito, et al.. (2025). Angiopoietin–TIE2 feedforward circuit promotes PIK3CA-driven venous malformations. Nature Cardiovascular Research. 4(7). 801–820. 4 indexed citations
2.
Ramamoorthy, Senthilkumar, Eirini Trompouki, Wolfgang Driever, et al.. (2024). Assessment of a novel NRAS in-frame tandem duplication causing a myelodysplastic/myeloproliferative neoplasm. Experimental Hematology. 133. 104207–104207. 1 indexed citations
3.
Berg, Sebastian, Annegret Holm, Etelka Foeldi, et al.. (2023). Complex Lymphatic Anomalies: Report on a Patient Registry Using the Latest Diagnostic Guidelines. Lymphatic Research and Biology. 21(3). 230–243. 7 indexed citations
4.
Seebauer, Caroline T., Constantin A. Hintschich, Natascha Platz Batista da Silva, et al.. (2023). Targeting the microenvironment in the treatment of arteriovenous malformations. Angiogenesis. 27(1). 91–103. 17 indexed citations
5.
Dompmartin, A., Eulàlia Baselga, Laurence M. Boon, et al.. (2023). The VASCERN-VASCA Working Group Diagnostic and Management Pathways for Venous Malformations. SHILAP Revista de lepidopterología. 4(2). e064–e064. 4 indexed citations
6.
Bassi, Andrea, Friedrich Kapp, Ilse Wieland, et al.. (2022). Cutis marmorata telangiectatica congenita being caused by postzygotic GNA11 mutations. European Journal of Medical Genetics. 65(5). 104472–104472. 5 indexed citations
7.
Kapp, Friedrich, et al.. (2022). Emicizumab in children: bleeding episodes and outcome before and after transition to Emicizumab. BMC Pediatrics. 22(1). 487–487. 11 indexed citations
8.
Baselga, Eulàlia, Laurence M. Boon, Andrea Diociaiuti, et al.. (2022). The VASCERN-VASCA working group diagnostic and management pathways for lymphatic malformations. European Journal of Medical Genetics. 65(12). 104637–104637. 9 indexed citations
9.
Cucuruz, Beatrix, Michael Koller, Urban W. Geisthoff, et al.. (2022). Towards a better treatment of patients with vascular malformations: certified interdisciplinary centers are mandatory. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 168. 1–7. 1 indexed citations
10.
Diociaiuti, Andrea, Eulàlia Baselga, Laurence M. Boon, et al.. (2022). The VASCERN-VASCA working group diagnostic and management pathways for severe and/or rare infantile hemangiomas. European Journal of Medical Genetics. 65(6). 104517–104517. 4 indexed citations
11.
Schneider, Michaela, et al.. (2022). Rhabdomyosarcoma xenotransplants in zebrafish embryos. Pediatric Blood & Cancer. 70(1). e30053–e30053. 2 indexed citations
12.
Holm, Annegret, D. Maroeska W. M. te Loo, Leo J. Schultze Kool, et al.. (2021). Efficacy of Sirolimus in Patients Requiring Tracheostomy for Life-Threatening Lymphatic Malformation of the Head and Neck: A Report From the European Reference Network. Frontiers in Pediatrics. 9. 697960–697960. 9 indexed citations
13.
Rößler, Jochen, Eulàlia Baselga, Verónica Celis, et al.. (2021). Severe adverse events during sirolimus “off‐label” therapy for vascular anomalies. Pediatric Blood & Cancer. 68(8). e28936–e28936. 29 indexed citations
14.
Speckmann, Carsten, et al.. (2020). Lipid Apheresis to Manage Severe Hypertriglyceridemia during Induction Therapy in a Child with Acute Lymphoblastic Leukemia. Pediatric Hematology and Oncology. 37(6). 530–538. 6 indexed citations
15.
Kapp, Friedrich, Julie R. Perlin, Elliott J. Hagedorn, et al.. (2018). Protection from UV light is an evolutionarily conserved feature of the haematopoietic niche. Nature. 558(7710). 445–448. 58 indexed citations
16.
Kapp, Friedrich, Anette Sommer, Thomas Kiefer, Gottfried Dölken, & Bernard Haendler. (2012). 5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis. Cancer Cell International. 12(1). 1–1. 57 indexed citations
17.
Kapp, Friedrich, Hans H. Maurer, Volker Auwärter, M. Winkelmann, & Maren Hermanns‐Clausen. (2011). Intrahepatic Cholestasis Following Abuse of Powdered Kratom (Mitragyna speciosa). Journal of Medical Toxicology. 7(3). 227–231. 116 indexed citations
18.
Kartal‐Kaess, Mutlu, Joerg J Meerpohl, Alexandra Fischer, et al.. (2011). Analysis of Ribosomal Protein Genes Associated with Diamond Blackfan Anemia (DBA) In German DBA Patients and Their Relatives. Blood. 118(21). 729–729. 3 indexed citations
19.
Kapp, Friedrich. (1970). Geschichte des deutschen Buchhandels bis in das siebzehnte Jahrhundert. 3 indexed citations
20.
Kapp, Friedrich & Hans Ulrich Wehler. (1969). Vom radikalen Frühsozialisten des Vormärz zum liberalen Parteipolitiker des Bismarckreichs : Briefe 1843-1884. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026